Blättern Human- und Zahnmedizin nach "Paulus, Walter Prof. Dr." Betreuer
Anzeige 1-6 von 6
-
Der Effekt der Pulsweite auf die kortikale Erregbarkeit hervorgerufen durch 5-Hz-cTMS
(2022-07-22)Repetitive Transcranial Magnetic Stimulation (rTMS) is known as an important diagnostic and therapeutic clinical tool, for example in treatment of depression. Here, we wanted to optimize stimulation parameters in order to ... -
Exzitabilitätsuntersuchungen von Motoneuronen an Patienten mit benignem Faszikulations-Crampus-Syndrom und die Funktion von HCN-Kanälen
(2016-02-02)Background: The mechanisms responsible for the benign cramp fasciculation syndrome (BFCS) are still not clarified. For the first time threshold tracking was performed on a bigger amount of BFCS patients. Methods: Threshold ... -
Long-term memory encoding of facial information in humans: an EEG and tACS study
(2021-07-27)In recent years, the investigation of memory formation and retrieval has attracted increasing interest. As oscillatory activity plays a crucial role in neuroplastic processes, episodic memory is to a considerable extent ... -
Messungen des Einflusses von Pregabalin auf die intra- und interhemisphärische Inhibition im humanen Motorkortex mittels transkranieller Magnetstimulation
(2011-06-08)Summary: Purpose: To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS). Methods: PGB, 600 mg/day, was orally administered ... -
Untersuchungen zur neuromuskulären Pathophysiologie bei der Charcot-Marie-Tooth-Typ-1A-Erkrankung
(2021-05-17)Charcot-Marie-Tooth type 1A Disease is the most common hereditary neuropathy with actually no causal treatment. The thesis evaluates whether the high-density surface electromyography (Multi-Unit-sEMG) with recording of 64 ... -
Über die Tumorigenität und den potenziellen Nutzen ausgewählter Stammzellersatztherapien in dem 6-Hydroxydopamin-Parkinsonmodell der Ratte
(2012-05-29)Parkinson's disease is the second most neurodegenerative disorder behind Alzheimer's disease. To date, treatments consist of symptomatic therapies, e.g. L-Dopa substitution, direct dopaminergic stimulation or deep ...